J and J Snack Foods News
News on J and J Snack Foods (Ticker: JJSF) continually updated from thousands of sources around the net.
4 hrs ago | Courier News
Heartbeats: Public campaign underway for Saint Peter's Health news from New Brunswick, Bernards, Branchburg, Woodbridge, Central Jersey Check out this story on mycentraljersey.com: http://mycj.co/1mydYkp The new and expanded Pediatric Emergency Department at Saint Peter's University Hospital in New Brunswick was completed in the spring of 2013 and ... (more)
Trending on the Topix Network
7 hrs ago | MSN Money
Johnson & Johnson, the world's biggest maker of health care products, plans to buy back up to $5 billion of the company's common stock.
Today I conclude my three-part series on mergers and acquisitions under the Foreign Corrupt Practices Act with a review of the post-acquisition phase.
Strong sales of several new drugs, particularly its hot new hepatitis medicine, lifted Johnson & Johnson's second-quarter profit by 13 percent, topping analysts' expectations.
A new twist to pretzels J&J Snack Foods Corp., Pennsauken, N.J., introduced a new twist to its S UPERPRETZEL brand.
But it wasn't just Olysio that drove growth. This 'sleepy' business segment turned in 6% worldwide growth at constant currency .
In Johnson & Johnson's second quarter 2014 earnings call today, one analyst asked chairman and CEO Alex Gorsky for his take on Gorsky's response, in essence, was that J&J saw something like this coming a mile away and beat its competitors to the punch.
Johnson & Johnson posted a 9.1% increase in sales of $19.5 billion for the second quarter of 2014.
Johnson & Johnson reported higher-than-expected quarterly results on sizzling sales of its new Olysio treatment for hepatitis C, but company officials cautioned the pill will lose steam later this year as newer rivals come to market.
Stock futures are modestly higher after a batch of generally positive economic reports and better than expected earnings results from JPMorgan Chase and Goldman Sachs; S&P +0.1% , Dow and Nasdaq +0.2% .
The results topped analysts' expectations. The maker of Band-Aids, medical devices and biologic drugs raised its 2014 profit forecast for the second time this year, again up by a nickel to a new range of $5.85 to $5.92 per share.
Johnson & Johnson reported higher-than-expected quarterly revenue and earnings, benefiting from strong sales of its Olysio treatment for hepatitis C. The diversified healthcare company on Tuesday said it had earned $4.33-billion, or $1.51 per share, in the second quarter.
When a woman's pickup stalled on a street in Santa Fe, New Mexico, local chef Jackson Ault stopped to lend a hand.
Bots. When data came out less than a year ago that a large amount of web clicks and online traffic is due to bots, and not people, the advertising community was furious.
Updated: Mon Jul 21, 2014 10:19 pm
Copyright © 2014 Topix LLC